tiprankstipranks
Lattice Biologics Ltd (TSE:LBL.H)
TSXV:LBL.H
Canadian Market

Lattice Biologics (LBL.H) Financial Statements

3 Followers

Lattice Biologics Financial Overview

Lattice Biologics's market cap is currently ―. The company's EPS TTM is C$; its P/E ratio is ―; Lattice Biologics is scheduled to report earnings on June 1, 2023, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 21Mar 21Dec 20Sep 20Jun 20
Income Statement-
Total Revenue-$ 287.65K$ 474.57K$ 795.78K$ 504.22K
Gross Profit-$ 3.79K$ 228.49K$ 212.27K$ 146.62K
EBIT$ -25.85K$ -389.42K$ -154.20K$ 217.40K$ -216.20K
EBITDA$ -25.85K$ -453.42K$ -90.19K$ 448.83K$ -179.16K
Net Income Common Stockholders--$ -269.13K$ -239.28K$ -319.74K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 25.85K$ 24.19K$ 57.22K$ 19.65K
Total Assets$ 606.43K$ 632.27K$ 2.87M$ 3.02M$ 2.48M
Total Debt$ 0.00$ 700.00K$ 3.28M$ 3.14M$ 3.01M
Net Debt$ 0.00$ 674.15K$ 3.26M$ 3.08M$ 2.99M
Total Liabilities$ 505.69K$ 2.23M$ 9.54M$ 9.42M$ 9.30M
Stockholders Equity$ 100.74K$ -1.59M$ -6.67M$ -6.40M$ -6.83M
Cash Flow-
Free Cash Flow$ 2.13K$ -539.75K$ -146.77K$ -108.71K$ 0.00
Operating Cash Flow$ 2.13K$ -539.75K$ -146.77K$ 459.07K$ 0.00
Investing Cash Flow--$ 0.00$ -567.79K$ 0.00
Financing Cash Flow$ -684.87K$ 571.13K$ 113.74K$ 155.82K$ 0.00
Currency in USD

Lattice Biologics Earnings and Revenue History

Lattice Biologics Debt to Assets

Lattice Biologics Cash Flow

Lattice Biologics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis